Kromek Group PLC Directorate Change (7668R)
26 September 2017 - 4:01PM
UK Regulatory
TIDMKMK
RNS Number : 7668R
Kromek Group PLC
26 September 2017
26 September 2017
Kromek Group plc
("Kromek" or the "Company")
Directorate Change
Kromek (AIM: KMK), a radiation detection technology company
focusing on the medical, security and nuclear markets, is pleased
to announce the appointment of Christopher Wilks as Non-Executive
Director of the Company with effect from 1 October 2017.
Christopher Wilks, 53, has considerable experience in the fields
of both science and finance. He is currently Chief Financial
Officer at Signum Technology, a leading group of specialised
engineering businesses operating in the safety and critical service
flow control sector, which he co-founded in 2012. Prior to Signum
Technology, Mr Wilks was Chief Financial Officer at Sondex plc;
Sondex is a specialist manufacturer of technical instruments for
the oil and gas industry. Christopher became the Chief Financial
Officer of Sondex in 1997 and in June 2003, he successfully managed
the listing of Sondex plc on the Main Market of the London Stock
Exchange. Sondex plc made several acquisitions in the period after
IPO and in 2007 GE acquired Sondex; during the five years from IPO
to acquisition by GE, the share price increased by a factor of 4.6
times.
A graduate of the University of Durham with a BSc in Applied
Physics and Electronics, Christopher has had a very successful
career. Initially joining Marconi Space Systems and applying his
degree education in the design of power systems for space craft,
Christopher then trained as a Chartered Accountant at Arthur Young
(now EY). After qualifying as a Chartered Accountant in audit he
became a Manager in the Corporate Finance team at Ernst &
Young.
Sir Peter Williams, Chairman of Kromek, said: "We are delighted
to welcome Christopher to the Board as Non-Executive Director. His
intimate understanding of the physics and financial worlds will add
valuable insight and expertise. Christopher's impressive record of
deal making and managing business growth at international
manufacturing organisations will help immeasurably as we roll out
our products to customers around the globe."
Commenting on his appointment as Non-Executive Director,
Christopher Wilks said: "As a graduate of the University of
Durham's physics department, I am thrilled to be joining Kromek at
this exciting time for the Company. In particular, I am keen to use
my international experience to support the management team
objective of achieving full commercial value for its impressive
radiation detection technology. I look forward to working with the
Board to deliver further value for shareholders in the future."
Mr Wilks owns 75,000 ordinary shares in Kromek, which represents
0.03 per cent. of the current issued share capital.
Christopher Wilks is currently or has been a director of the
following companies within the previous five years:
Current directorships
Signum Technology Ltd and its subsidiary companies,
including:
Copper Midco 1 Limited
Cooper Midco 2 Limited
Cooper Bidco Limited
Gall Thomson International Limited
Klaw Products Limited
Vee Bee Limited
Vee Bee Filtration (UK) Limited
Filtration & Valves Limited
Past directorships
Falcon Oilfield Services LLC
Mr Wilks was a director of Clearwater Industries between 1994
and 1996. In 1996, Clearwater Industries was put into liquidation
and was sold two days later. The creditor shortfall was
approximately GBP100,000.
There is no further information required to be disclosed
pursuant to Schedule Two, paragraph (g) of the AIM rules.
Enquiries
Kromek Group plc
-------------------------------- ---------------
Arnab Basu, CEO +44 (0)1740
Derek Bulmer, CFO 626 060
-------------------------------- ---------------
Cenkos Securities plc
-------------------------------- ---------------
Bobbie Hilliam (NOMAD) +44 (0)20 7397
Julian Morse (Sales) 8900
-------------------------------- ---------------
Luther Pendragon Ltd
-------------------------------- ---------------
Harry Chathli, Claire Norbury, +44 (0)20 7618
Alexis Gore 9100
-------------------------------- ---------------
About Kromek Group plc
Kromek Group plc is a UK technology Group (global HQ in County
Durham) and a leading developer of high performance radiation
detection products based on cadmium zinc telluride ("CZT") and
other advanced technologies. Using its core technology platforms,
Kromek designs, develops and produces x-ray and gamma ray imaging
and radiation detection products for the medical, security
screening and nuclear markets.
The Group's products provide high resolution information on
material composition and structure and are used in multiple
applications, ranging from the identification of cancerous tissues
to hazardous materials, such as explosives, and the analysis of
radioactive materials.
The Group's business model provides a vertically integrated
technology offering to customers, from radiation detector materials
to finished products or detectors, including software, electronics
and application specific integrated circuits ("ASICs").
The Group has operations in the UK and US (California and
Pennsylvania), and is selling internationally through a combination
of distributors and direct OEM sales.
Currently, the Group has over one hundred full time employees
across its global operations. Further information on Kromek Group
is available at www.kromek.com and
https://twitter.com/kromekgroup.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOALLFSDARIEFID
(END) Dow Jones Newswires
September 26, 2017 02:01 ET (06:01 GMT)
Kromek (LSE:KMK)
Historical Stock Chart
From Apr 2024 to May 2024
Kromek (LSE:KMK)
Historical Stock Chart
From May 2023 to May 2024